November 14, 2016
WASHINGTON, DC—The National Committee for Quality Assurance (NCQA) invites the public to comment on Healthcare Effectiveness Data and Information Set (HEDIS®) and Consumer Assessment of Healthcare Providers and Systems (CAHPS®) measures included in Health Plan Accreditation (HPA) for the 2018 reporting year. This is an opportunity for health plans, purchasers, consumers and other stakeholders to weigh in on the relevance and feasibility of measures proposed for scoring in HPA.
NCQA proposes to add these measures to those scored in HPA:
- For commercial, Medicare and Medicaid plans:
- Statin Therapy for Patients With Cardiovascular Disease (SPC) (both rates).
- Statin Therapy for Patients With Diabetes (SPD) (both rates).
- Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) (Initiation of AOD Treatment rate).
- For commercial and Medicare plans:
- Risk Adjusted Emergency Department Utilization (EDU).
- For Medicare plans:
- Non-Recommended PSA-Based Screening in Older Men (PSA).
- For Medicaid plans:
- Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA).
- NCQA proposes to remove these measures from scoring in HPA
- For commercial, Medicare and Medicaid plans:
- Comprehensive Diabetes Care (Medical Attention for Nephropathy rate).
- Comprehensive Diabetes Care (HbA1c Poor Control (>9%) rate).
- For commercial plans:
- Medical Assistance With Smoking and Tobacco Use Cessation (Advising Smokers to Quit rate).
- For Medicare plans:
- Adult BMI Assessment
The public comment site is https://www.ncqa.org/homepage/ncqa-public-comments.